# VASO CORPORATION (VASO) · Edgar & Edgarette company card

> Vaso (VASO) grew revenue 2.7% in FY2025 to $89 million, operating margin -3.2% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 33.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 839087 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/VASO) · [JSON](https://www.pops4.com/boards/company/VASO.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $89M |
| Revenue growth, 1 year | 2.7% |
| Revenue growth per year | 4.2% |
| Operating margin | -3.2% (prior year 0.3%) |
| Net margin | 1.8% |
| Operating cash flow | $9M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $35M |
| Long-term debt | — |
| Total assets | $88M |
| Total equity | $29M |
| Equity ÷ assets | 33.3% |
| Return on equity | 5.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 0.72 (distress zone)
- Piotroski F: 8 of 9 (strong)
- Beneish M: -2.97 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · revenue is hard to predict: its 80% range is ±26%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $89.1M (FY2025). Experience: revenue up 2.7% on the year, up 4.2% a year over 4 years; operating margin -3.2%, down from 0.3%. Soundness: equity 33.3% of assets, return on equity 5.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $68.5M and $116.5M next year (method v4.1: its own 6-year record of growth weighed at 63% against $50M–100M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $69.9M to $114.4M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin -3.2% against a 7.5% median; growth 2.7% against 8.3%.

Range logged 2026-10-30, receipt 5cc9d22bdaa12b55, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-07-23 ([filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026080991/0001213900-26-080991-index.htm))

## Recent filings

- DEF 14A · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026113710/0001213900-26-113710-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026090009/0001213900-26-090009-index.htm)
- 8-K · filed 2026-07-31 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026084076/0001213900-26-084076-index.htm)
- 8-K · filed 2026-07-23 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026080991/0001213900-26-080991-index.htm)
- 10-Q · filed 2026-05-15 · [filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026057690/0001213900-26-057690-index.htm)
- 8-K · filed 2026-05-08 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/839087/000121390026053854/0001213900-26-053854-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000839087.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=839087

## Cite

POPS4, Edgar & Edgarette: VASO CORPORATION (VASO) company card, from the company's own SEC filings, accessed 2026-10-30, https://www.pops4.com/boards/company/VASO. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.